UPC revives patent, but timing sinks Guardant’s appeal ...

Otsuka v Sun Pharma could redefine which pharmaceutical patents qualify for patent term extensions, with major implications ...

Deal is aimed at strengthening German company’s presence across high-growth life sciences markets by adding a portfolio of ...

A federal court has ruled in a dispute between a clinical trial technology company and a psychedelic drug developer over ...

HGF expands European offering with pair of in-house hires ...

Novartis will work with a US biotech company on new cancer therapies, while Lilly has partnered with a Chinese biopharma firm ...

Ashurst Perkins Coie opens its doors following landmark merger ...

Despite the flexibilities embedded in the TRIPS Agreement and reaffirmed by the Doha Declaration, timely access to vaccines ...

A new report warns that sweeping procurement reforms in Mainland China, alongside open robotics platforms, supply chain disruption and GLP-1 drugs, are changing competition and challenging ...

A first-chair trial lawyer with two decades in high-stakes patent and trade secret disputes brings experience across medical devices, biologics, and pharmaceuticals, alongside a broader ...

The latest additions bring experience representing technology and medical device companies in complex patent and commercial disputes, with the firm extending its run of bringing in partners from ...